United States Nootropic Market Overview, 2031

Key Insights

• According to the research report, "U.S. Nootropics Market Outlook, 2031," published by Bonafide Research, the U.S. Nootropics Market is anticipated to grow at more than 12.54% CAGR from 2026 to 2031. The U.S. nootropics market is increasingly being absorbed into the broader brain-health and cognitive-wellness economy, making the category larger than products explicitly marketed as nootropics. Consumers are encountering cognitive functionality through supplements, functional beverages, energy products, mushroom-based formulations, healthy-aging products, and nutrition solutions positioned around focus, memory, calm, and mental energy. This creates an important market-sizing distinction: growth in cognitive-function products may outpace growth in products carrying the nootropic label itself.
• The U.S. market is developing around two distinct demand engines performance optimization among younger adults and cognitive preservation among older adults. Younger consumers create demand around concentration, productivity, studying, gaming, mental stamina, and energy, where nootropics compete heavily with coffee and energy products. Older consumers represent a fundamentally different opportunity centered on memory, maintaining cognitive function, and healthy aging, supported by an already established habit of dietary-supplement consumption. These two groups differ significantly in expected benefits, product formats, trust requirements, and willingness to experiment.
• The U.S. market faces a credibility gap that could become a major Distribution Channel of competitive consolidation. Nootropic is not a single FDA regulatory category, and products promoted under the term range from conventional dietary ingredients to substances that cannot legally be marketed as dietary supplements. The most important hidden opportunity is the large population experiencing cognitive-performance problems without identifying themselves as nootropic consumers. Everyday problems such as afternoon mental fatigue, prolonged screen exposure, difficulty sustaining attention, poor sleep affecting next-day performance, work-related cognitive overload, and age-related concern about memory create demand far beyond traditional biohacking audiences.

Market Outlook

• The U.S. nootropics market is increasingly developing around two fundamentally different demand engines: performance optimization among younger and working-age consumers and cognitive preservation among older adults. Attention & Focus is closely tied to students, professionals, gamers, and cognitively intensive lifestyles, where consumers seek concentration, alertness, and mental stamina, while Memory Enhancement and Longevity & Anti-aging increasingly address longer-term concerns around maintaining cognitive capability. This second demand pool is becoming structurally more important as the U.S. population aged 65 and above reached approximately 61.2 million in 2024, increasing 3.1% in just one year.
• The United States represents a highly developed market for nootropics, supported by an established dietary-supplement culture, high consumer spending on wellness, growing interest in cognitive performance, and increasing attention to maintaining brain health across different life stages. Nootropics are gradually moving beyond their earlier association with biohacking and performance enhancement and becoming part of the wider cognitive-wellness landscape. Consumers increasingly seek products for memory support, concentration, mental energy, emotional well-being, stress management, sleep and recovery, and healthy cognitive aging.
• Over the forecast period, the U.S. nootropics market is expected to become increasingly integrated with the broader functional nutrition and wellness industry. Growth opportunities are likely to extend beyond conventional memory and focus supplements into cognitive aging, stress management, sleep-related recovery, functional beverages, convenient on-demand formats, and personalized cognitive-wellness routines.

Market Dynamics

Driver: Rising Stress, Sleep Problems, and Mental-Wellness Awareness High stress levels, inadequate sleep, burnout, and growing awareness of the relationship between mental wellness and cognitive performance are broadening nootropic demand beyond traditional memory enhancement. Consumers increasingly seek integrated solutions for calm focus, stress support, sleep quality, recovery, mood support, and next-day cognitive performance.

Challenge: High Market Fragmentation and Ingredient Commoditization Gap Low barriers to contract manufacturing allow numerous brands to launch similar formulations using caffeine, L-theanine, adaptogens, functional mushrooms, and other widely available ingredients. Product similarity intensifies price competition and makes sustainable differentiation increasingly difficult without proprietary formulations, clinical evidence, branded ingredients, or advanced delivery systems.

Trend: Rapid Rise of Functional Nootropic Beverages and Alternative Formats Consumer preference is expanding from traditional Capsules/Tablets toward functional drinks, powders, mushroom coffees, gummies, gums, mints, shots, and stick packs. These convenient formats are integrating nootropics into everyday work, study, gaming, and wellness routines.

Regulatory Affairs Landscape

• The principal federal framework for dietary supplements derives from the Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Dietary Supplement Health and Education Act of 1994 (DSHEA). Unlike new drugs, dietary supplements generally do not undergo FDA premarket approval for safety and effectiveness before reaching consumers.
• FDA's attention to this issue remains active. In March 2026, the agency held a public meeting titled “Exploring the Scope of Dietary Supplement Ingredients” to inform its consideration of the dietary-ingredient categories established under DSHEA. This is particularly relevant for innovative supplement categories such as nootropics, where new compounds may not fit straightforwardly within conventional vitamin, mineral, botanical, amino-acid, or other statutory ingredient categories.
• Product claims represent one of the most important regulatory boundaries across Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-aging, Sleep & Recovery, and Anxiety applications. Dietary supplements can make certain qualifying structure/function claims, provided applicable statutory and regulatory requirements are satisfied.

Production & Supply Chain Dynamics

• Raw material sourcing for the U.S. nootropics industry is highly globalized, with botanical and specialty ingredients Distribution Channeld according to cultivation suitability, processing expertise, and established supplier networks. Ashwagandha and Bacopa monnieri have strong sourcing bases in India, while Rhodiola rosea is associated with colder growing regions across Europe and Asia, and Ginkgo-derived ingredients are supplied through established Asian botanical-processing networks. Dependence on geographically concentrated botanical Distribution Channels exposes manufacturers to crop variability, weather conditions, harvest cycles, freight disruptions, and changes in import costs.
• Synthetic and processed nootropic ingredients including Caffeine Anhydrous, L-Theanine, Alpha-GPC, Citicoline/CDP-Choline, amino acids, vitamins, and specialty compounds are Distribution Channeld through international ingredient-manufacturing networks, with Asia remaining an important upstream production base for the broader dietary-supplement industry. U.S. dependence on imported supplement inputs has become increasingly important as tariffs and trade-policy changes affect landed costs and procurement planning. Multi-ingredient nootropic formulations are particularly exposed because cost increases across several imported inputs can accumulate within a single finished product.

Industry News

• In January 2026, Ultra raised USD 11 million to scale its functional focus-pouch business. The U.S.-based company secured the funding to expand its nicotine-free performance pouch offerings and strengthen its market presence. Ultra’s formulation combines paraxanthine with functional ingredients such as L-theanine, Alpha-GPC, B vitamins, and ginseng extract, targeting consumers seeking improved focus, energy, and cognitive performance without nicotine.
• In July 2025, BioAdaptives announced the national launch of NeuroRush in the United States. Nevada-based BioAdaptives introduced NeuroRush, an adaptogenic nootropic formulation designed to support mental clarity, focus, stress resilience, and long-term cognitive health.
• In 2025, Graymatter secured USD 1.3 million in investment to expand its daily brain-health product portfolio. The company raised the funding to advance its mission of making brain health part of everyday wellness routines and to support the growth of its cognitive-performance offerings, including Bright Mind.

Segment Analysis

United States Nootropics Market By Form • Capsules/Tabletsrepresent the largest and most established form in the U.S. nootropics market, supported by their compatibility with multi-ingredient formulations, precise serving control, long shelf stability, portability, and widespread consumer familiarity with dietary supplements. The format is particularly strong across Memory Enhancement, Longevity & Anti-aging, and daily Attention & Focus formulations, where consumers typically follow consistent supplementation routines rather than seeking an immediate consumption experience. Capsules also allow manufacturers to combine botanical extracts, amino acids, vitamins, minerals, phospholipids, and specialty cognitive ingredients without the taste and solubility challenges associated with beverages and powders. From a production perspective, mature contract-manufacturing infrastructure and standardized encapsulation or tableting processes make solid-dose products comparatively scalable, reinforcing their dominance among both established supplement companies and digitally native nootropic brands.
• Powders represent the fastest-growing volume segment. Driven by the "mix-it-yourself" culture among fitness enthusiasts and health-conscious consumers, powders offer superior price-per-serving economics, higher dosage flexibility, and convenient stick-pack portability. However, taste and texture remain significant friction points; brands winning this segment are those with superior flavor-masking technologies using natural sweeteners (stevia, monk fruit) and fruit extracts. Manufacturers have invested heavily in micronization (reducing particle size for faster dissolution), anti-clumping technologies (silicon dioxide, rice flour), and natural flavor systems to improve consumer experience. Premium powder stick-packs retail for USD 3–6 per serving, while bulk canisters offer effective per-serving costs of USD 1–2. Bulk canisters appeal to heavy daily users seeking value, while stick-packs target on-the-go consumers prioritizing convenience.
• Drinks (RTD beverages) represent the highest growth rate segment. This segment is disrupting traditional energy drinks, with nootropic-infused sparkling waters, shots, and functional beverages gaining rapid traction in convenience stores, gyms, supermarket coolers, and college campuses. RTD drinks appeal to younger, on-the-go consumers seeking "functional hydration" rather than pill-based supplementation, offering enhanced sensory experience through flavors, carbonation, and mouthfeel. However, this segment carries the highest production costs due to specialized aseptic processing, heavy packaging (aluminum cans, glass bottles), logistics weight, and shelf-life testing.
• Others (Gummies, Sublingual Sprays, Oral Strips, Transdermal Patches, Soft Gels) constitute the remaining segment. Gummies are particularly popular for the Sleep & Recovery and Anxiety application segments due to their palatability, treat-like consumption experience, and appeal to consumers who struggle with pill swallowing. Gummy formulations require specialized manufacturing for texture, stability, and accurate dosing, carrying higher production costs than capsules.

United States Nootropics Market By Application • Memory Enhancement represents one of the most established application segments in the U.S. nootropics market, supported by growing consumer attention to cognitive maintenance, age-related memory changes, and preventive brain health. Demographic aging provides a structural demand base, the U.S. Census Bureau projects that by 2030 all baby boomers will be age 65 or older, increasing the population exposed to age-associated cognitive concerns. The segment is not limited to older adults, however, as students and working-age consumers also use memory-oriented supplements for learning, information retention, and broader cognitive support. Common formulation ingredients include Bacopa monnieri, phosphatidylserine, Ginkgo biloba, choline-related compounds, vitamins, and other botanical or nutritional ingredients positioned around memory and cognitive function.
• Attention & Focusrepresents a major performance-driven application with a broad consumer base spanning students, professionals, remote and hybrid workers, gamers, shift workers, entrepreneurs, and other consumers facing sustained cognitive workloads. Unlike Memory Enhancement, where benefits are generally positioned around longer-term support, Attention & Focus products often compete on a more immediate consumer expectation: improved alertness, concentration, mental energy, or ability to sustain cognitively demanding tasks. Common formulations incorporate caffeine, L-theanine, tyrosine, Alpha-GPC, citicoline/CDP-choline, Rhodiola rosea, and other ingredients associated with alertness, neurotransmitter precursors, or fatigue management.
• Anxiety is an increasingly important wellness-oriented application as consumers seek products positioned around stress management, relaxation, calmness, and emotional balance. Demand is particularly relevant among younger adults and working-age consumers facing workplace pressure, financial stress, digital overstimulation, and lifestyle-related burnout. The American Psychiatric Association's 2024 annual mental-health poll found that 43% of U.S. adults reported feeling more anxious than the previous year, up from 37% in 2023 and 32% in 2022, illustrating the broader environment supporting consumer interest in stress and calmness oriented wellness solutions.
• Sleep & Recovery is expanding as consumers increasingly recognize the relationship between sleep quality and daytime cognitive performance. CDC data published in 2026 show that 30.5% of U.S. adults averaged less than seven hours of sleep per day in 2024, demonstrating a large underlying population experiencing insufficient sleep. The commercial opportunity extends beyond consumers seeking faster sleep onset; products increasingly target sleep quality, relaxation, nighttime recovery, and next-day functioning.
• Mood & Depression represents one of the most regulatory-sensitive application areas within the market. Consumer interest is supported by broader awareness of emotional wellness and growing acceptance of discussing mental health, but companies face strict limitations on how dietary supplements can be marketed. Products typically incorporate ingredients such as saffron extract, SAMe, St. John's wort, 5-HTP, inositol, vitamins, minerals, and other compounds associated with mood-related research.
• Longevity & Anti-aging represents an emerging premium-oriented application at the intersection of cognitive wellness, cellular health, and healthy aging. Consumer interest is being driven by the broader U.S. longevity movement, increasing attention to healthspan rather than lifespan alone, and demand among higher-income wellness consumers for products positioned around maintaining physical and cognitive function with age

United States Nootropics Market By Distribution Channel • Online represents the most strategically important distribution channel for the U.S. nootropics market, supported by high e-commerce penetration, the research-intensive nature of cognitive supplements, broad product availability, and the rapid expansion of direct-to-consumer brands. DTC websites give brands greater control over pricing, consumer education, product bundling, first-party customer data, and retention strategies. Brands including Qualia, Mind Lab Pro, Onnit, and other cognitive-wellness companies have used detailed ingredient education, scientific content, quizzes, product bundles, and subscription options to build direct relationships with consumers rather than depending exclusively on third-party retailers.
• Offline remains an important distribution channel as nootropics increasingly move from specialist supplementation toward mainstream cognitive wellness. Physical retail provides immediate availability, product visibility, and credibility among consumers who prefer purchasing supplements from familiar stores. Offline distribution spans specialty nutrition retailers, mass merchants, warehouse clubs, supermarkets, pharmacies, convenience outlets, gyms, and other wellness-oriented locations.
• Over the forecast period, Online is expected to remain structurally important for specialized nootropics and innovation-led brandsbecause of its ability to support detailed product education, broad assortment, subscriptions, and rapid product testing. Offline is expected to gain strategic importance as cognitive wellness becomes more mainstream, particularly for Capsules/Tablets, sleep and stress-support products, functional beverages, and recognizable brain-health formulations.



Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Nootropics Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Form
• Capsules/Tablets
• Powder
• Drinks
• Others

By Application Type
• Memory Enhancement
• Mood & Depression
• Attention & Focus
• Longevity & Anti-aging
• Sleep & Recovery
• Anxiety

By Distribution Channel
• Online
• Offline